Sugi Predict

Sugi Predict / Compounds / SCHEMBL2125458

SCHEMBL2125458

SCHEMBL2125458

COC(=O)C1CC2CC(=O)C1C2

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.37
▸ SLC6A3 Q01959 3/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ MMP2 P08253 1/20 0.33
▸ ANPEP P15144 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30444800 1.00 BRD4 (0.37) BRD4SLC6A3SLC6A4CYP3A4CYP1A2
SCHEMBL30445083 1.00 BRD4 (0.37) BRD4SLC6A3SLC6A4CYP3A4CYP1A2
SCHEMBL11384348 0.87 SLC6A3 (0.36) BRD4SLC6A3SLC6A4CHRM2CHRM4
SCHEMBL5162001 0.78 GABRR1 (0.36) —
SCHEMBL2128128 0.78 GABRR1 (0.36) —
SCHEMBL30445280 0.78 SLC6A3 (0.32) SLC6A3CYP3A4CYP1A2CYP2D6TSHR
SCHEMBL974399 0.71 CHRM2 (0.48) CYP3A4CYP1A2CYP2D6TSHRMAPK1
SCHEMBL1298159 0.71 CHRM2 (0.48) CYP3A4CYP1A2CYP2D6TSHRMAPK1
SCHEMBL974796 0.71 CHRM2 (0.48) CYP3A4CYP1A2CYP2D6TSHRMAPK1
SCHEMBL31285391 0.71 CHRM2 (0.48) CYP3A4CYP1A2CYP2D6TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405342-A2 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-07-31 — — EP disclosed
WO-2023049829-A2 CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-03-30 — — WO disclosed
EP-3427738-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2021-12-01 — — EP disclosed
US-10874673-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-12-29 — — US disclosed
CN-104922128-B Inhibitors of influenza virus replication 沃泰克斯药物股份有限公司 2019-12-20 — — CN disclosed
CN-110540538-A Inhibitors of influenza virus replication VERTEX PHARMA 2019-12-06 — — CN disclosed
US-20190151314-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED 2019-05-23 — — US disclosed
EP-3427738-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Incorporated (US) 2019-01-16 — — EP disclosed
US-10039762-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-08-07 — — US disclosed
US-10039762-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-08-07 — — US disclosed
US-20120171245-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-05 — — US disclosed
US-20120171245-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-05 — — US disclosed
EP-2442809-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Incorporated (US) 2012-04-25 — — EP disclosed
WO-2010148197-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-23 — — WO disclosed
WO-2010148197-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-23 — — WO disclosed
EP-1064256-B1 BICYCLO [2.2.1] HEPTANES AND RELATED COMPOUNDS PFIZER PROD INC (US) 2004-08-04 — — EP disclosed
EP-1396273-A1 Bicyclo(2.2.1.)heptanes and related compounds Pfizer Products Inc. (US) 2004-03-10 — — EP disclosed
EP-1064256-A1 BICYCLO [2.2.1] HEPTANES AND RELATED COMPOUNDS Pfizer Products Inc. (US) 2001-01-03 — — EP disclosed
US-6136861-A Bicyclo[2.2.1]heptanes and related compounds PFIZER INC (US) 2000-10-24 — — US disclosed
WO-1999047490-A1 BICYCLO[2.2.1]HEPTANES AND RELATED COMPOUNDS PFIZER PRODUCTS INC. (US) 1999-09-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190151314-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION ACE, IRF3, ACE2 BRD4 1024/4885SLC6A3 3141/4885SLC6A4 1743/4885
US-10874673-B2 Inhibitors of influenza viruses replication ACE, IRF3, ACE2 BRD4 1024/4885SLC6A3 3141/4885SLC6A4 1743/4885
US-20120171245-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION ACE, IRF3, ACE2 BRD4 1024/4885SLC6A3 3141/4885SLC6A4 1743/4885
US-10039762-B2 Inhibitors of influenza viruses replication ACE, IRF3, ACE2 BRD4 1024/4885SLC6A3 3141/4885SLC6A4 1743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.